Skip to content

Author

Nannapat Triluksanavilai

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Flavaglines as cross-kingdom translation inhibitors: Heavy halides at C6 potentiate antineoplastic, antiviral, and antifungal activities.

This is the first systematic SAR study directly comparing the anticancer and antipathogenic activities of flavagline derivatives, or any other known translation inhibitors, or any other known translation inhibitors.

D. Vrubliauskas, J. Yahuafai, Nathakorn Nuntapong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.